Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China.

Zhao H, Sun Y, Yao X, Shen P, Lin H, Zhan S

Open source

DOI
10.1080/14787210.2024.2368823
Published
2024 Nov
Container
Expert review of anti-infective therapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14787210.2024.2368823,
  title = {Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China.},
  author = {Zhao H and Sun Y and Yao X and Shen P and Lin H and Zhan S},
  year = {2024},
  journal = {Expert review of anti-infective therapy},
  doi = {10.1080/14787210.2024.2368823},
  url = {https://doi.org/10.1080/14787210.2024.2368823}
}

RIS

TY  - JOUR
TI  - Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China.
AU  - Zhao H
AU  - Sun Y
AU  - Yao X
AU  - Shen P
AU  - Lin H
AU  - Zhan S
PY  - 2024
JO  - Expert review of anti-infective therapy
DO  - 10.1080/14787210.2024.2368823
UR  - https://doi.org/10.1080/14787210.2024.2368823
ER  - 

APA

H, Z., Y, S., X, Y., P, S., H, L., & S, Z. (2024). Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China.. Expert review of anti-infective therapy. https://doi.org/10.1080/14787210.2024.2368823

Source records